During the past decade, Irmandade da Santa Casa da Misericórdia de Santos conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Irmandade da Santa Casa da Misericórdia de Santos" are "Crohn's Disease" (3 trials), "Colitis, Ulcerative" (2 trials) and "Crohn Disease" (1 trials). Many other conditions were trialed in "Irmandade da Santa Casa da Misericórdia de Santos" in a lesser frequency.

Most popular intervention types in "Irmandade da Santa Casa da Misericórdia de Santos" are "Drug" (5 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Golimumab" (2 trials), "Guselkumab" (2 trials), "JNJ-78934804" (2 trials) and "Guselkumab Dose 1" (1 trials). Other intervention names were less common.

The vast majority of trials in "Irmandade da Santa Casa da Misericórdia de Santos" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Irmandade da Santa Casa da Misericórdia de Santos". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Irmandade da Santa Casa da Misericórdia de Santos, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Irmandade da Santa Casa da Misericórdia de Santos, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".